Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05665465Phase 1Recruiting
Phase 1, randomised trial of nicotine patch (3 arms), sponsored by Duke University. Primary endpoints: Subjective effects of nicotine nasal spray as measured by the Nicotine Effects Questionnaire, Subjective effects of nicotine nasal spray as measured by a visual analog scale and 3 more. Started Jan 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05665465.